Recent

% | $
Quotes you view appear here for quick access.

Acorda Therapeutics, Inc. (ACOR) Message Board

  • biotech_jim biotech_jim Jan 29, 2013 11:00 PM Flag

    Fampyra to aid Stroke victims

    ACOR is running a phase 2 trial to determine whether or not Fampyra shows promise with stroke patients. Has anyone done the work as to what shareholders can expect in the way of value creation if the trial is a success?

 
ACOR
32.00-0.26(-0.81%)12:20 PMEDT